Hyperhomocysteinemia (HHcy) is an important potential risk factor for cardiovascular and cerebrovascular disease, senile dementia and other diseases.

Lowering homocysteine levels has been shown to slow the atrophication of areas of the brain specifically effected by Alzheimer’s Dementia by up to 9-fold (Douaud, 2013).

A folate regime conferred the performance of someone younger by (Durga, 2007):
    · 4.7 years for memory
    · 1.5 years for global cognitive function
    · 6.7 years for delayed recall

Magnafolate® shows good effect on cognitive Improvement, Dementia & Alzheimer.